EMCDDA Home
  • EN
Search

Table TDI-109. All clients entering inpatient treatment by primary drug and age at first use, 2011 or most recent year available

Part (iii) All stimulants (other than cocaine) inpatient clients by country and age at first use

Country<1515-1920-2425-2930-3435-3940-4445+Age knownAge not knownTotal
Belgium20461753200937100
Bulgaria04100000527
Czech Republic201917250793515141502441546
Denmark21201010016117
Germany132501113272234480659865
Estonia:::::::::::
Ireland15841001019423
Greece03000000303
Spain:::::::::::
France02200000404
Italy:::::::::::
Cyprus02200000404
Latvia:::::::::::
Lithuania:::::::::::
Luxembourg:::::::::::
Hungary157314671001160116
Malta:::::::::::
Netherlands17329332116865133
Austria11741100024226
Poland2631111971::::10:
Portugal:::::::::::
Romania112100005611
Slovenia:::::::::::
Slovakia26155501952012581259
Finland12532025410977104
Sweden12234539429236828380838
United Kingdom31624135001160666
Croatia:3:1:::::5:
Turkey3653100018119
Norway43113252161123024721268
Total768255567120611738201341832414409
 

Notes:

: Indicates no data are available.

(1) Data are from 2010.

(2) Data are from 2009. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.

(3) Data are from 1st of April 2010 to 31st March 2011.

(4) In Norway the criteria for selecting and grouping cases are main ICD-10 diagnosis codes F11-F16 and F18-F19.

The number of treatment clients in each country is listed in TDI-7

See also Table TDI-11 part(vii), part(viii)

‘General notes for interpreting data'’ on the Explanatory notes and help page.

Source:

Reitox national reports 2011- Table TDI Inpatient Treatment Centres

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 26 April 2013